Hong Kong biotech stock surges 56,000% with no revenue, CEO becomes mega-billionare overnight
A Hong Kong company developing herbal treatments for ADHD has seen its stock price surge over 56,000% this year following a 38-for-1 stock split, despite having no revenue and ongoing losses.
Regencell Bioscience CEO Yat-Gai Au's 86% stake in the company is now worth $25.6 billion, as reported by Bloomberg.
The company has …
 | A guest post by
|